113 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
to attend the virtual annual meeting?”.
How many shares must be represented to have a quorum and hold the annual meeting?
A majority of our shares … a majority of the votes cast on the matter must vote FOR the proposal. Shares held in street name by nominees who indicate on their proxies
8-K
EX-99.1
SYRS
Syros Pharmaceuticals Inc.
8 Jan 24
Regulation FD Disclosure
7:06am
+ azacitidine4,5 The majority of non-hematologic AEs have been low grade and reversible2-5 Well-characterized in over 1,000 acute promyelocytic leukemia (“APL
8-K
EX-4.1
pxaww
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
8-K
EX-1.1
n103vpaur2o6c24g
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
424B5
tj9o7da
19 Dec 23
Prospectus supplement for primary offering
4:53pm
8-K
EX-99.2
vky1asu7
6 Dec 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
dx2yzg6 voj
6 Dec 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
w4ndg7kd1bzr884w
25 May 23
Regulation FD Disclosure
5:10pm
424B5
qavsbl k0zx
1 May 23
Prospectus supplement for primary offering
4:06pm